Here at Throne Biotechnologies, we are pleased to announce Dr. Robin Ross, M.D., MPH, CPH as our Director of Ophthalmology. Dr. Ross is the Board Certified American Board of Ophthalmology

Paramus, New Jersey (April 24, 2024) - Throne Biotechnologies is one of the global-leading biotech companies aiming to find a cure for type 1 diabetes. We are excited to announce

We are pleased to announce that Dr. Yong Zhao collaborated with his colleagues Dr. Robert Korngold’s group at the Center For Discovery and Innovation (CDI) of Hackensack Meridian Health, published

We are happy to announce that Dr. Yong Zhao and his team published a new manuscript that revealed the new molecular mechanisms underlying Stem Cell Educator therapy for the treatment

Over the last year, Throne has made significant progresses in the FDA-approved clinical trials of Stem Cell Educator therapy for the treatment of type 1 diabetes (T1D), alopecia areata (AA)

We are pleased to announce that Dr. Yong Zhao, founder and CEO of Throne Biotechnologies, is invited by an academic journal Biomedicines to edit Special Issue, “Mitochondria in Human Health

Here at Throne Biotechnologies, we are pleased to announce Dr. Richard Fox, M.D., as our Pediatric Medical Director. Dr. Fox received his medical degree from the University of Minnesota in 1975

Type 1 diabetes (T1D) is an autoimmune disease with a shortage of islet β cells. To date, the etiology of T1D remains elusive. Increasing clinical evidence and animal studies demonstrate